Westpac Banking Corp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2M Sell
80,033
-12,214
-13% -$1.71M 0.78% 20
2025
Q4
$11.3M Buy
92,247
+5,787
+7% +$703K 0.72% 23
2025
Q3
$9.6M Hold
86,460
0.59% 32
2025
Q2
$9.59M Buy
86,460
+2,027
+2% +$216K 0.64% 28
2025
Q1
$9.46M Buy
84,433
+4,135
+5% +$427K 0.7% 27
2024
Q4
$7.42M Buy
80,298
+1,449
+2% +$130K 0.49% 40
2024
Q3
$6.61M Buy
78,849
+3,416
+5% +$261K 0.44% 52
2024
Q2
$5.18M Hold
75,433
0.41% 53
2024
Q1
$5.53M Sell
75,433
-922
-1% -$70.9K 0.42% 53
2023
Q4
$6.19M Sell
76,355
-2,662
-3% -$207K 0.51% 49
2023
Q3
$5.92M Sell
79,017
-621
-0.8% -$47.8K 0.44% 50
2023
Q2
$6.14M Sell
79,638
-177,412
-69% -$14.1M 0.43% 50
2023
Q1
$21.3M Sell
257,050
-36,816
-13% -$3.05M 0.29% 82
2022
Q4
$25.2M Buy
293,866
+138,537
+89% +$11M 0.37% 57
2022
Q3
$9.58M Buy
155,329
+11,022
+8% +$695K 0.15% 189
2022
Q2
$8.92M Buy
144,307
+36,489
+34% +$2.26M 0.12% 241
2022
Q1
$6.41M Buy
107,818
+4,526
+4% +$289K 0.07% 336
2021
Q4
$7.5M Buy
103,292
+227
+0.2% +$15.6K 0.08% 308
2021
Q3
$7.2M Sell
103,065
-9,208
-8% -$647K 0.08% 335
2021
Q2
$7.73M Sell
112,273
-5,861
-5% -$391K 0.08% 323
2021
Q1
$7.63M Sell
118,134
-25,494
-18% -$1.64M 0.08% 303
2020
Q4
$8.37M Sell
143,628
-4,607
-3% -$278K 0.1% 282
2020
Q3
$9.37M Buy
148,235
+6,839
+5% +$474K 0.13% 202
2020
Q2
$10.9M Sell
141,396
-37,110
-21% -$2.84M 0.16% 160
2020
Q1
$13.3M Sell
178,506
-95,265
-35% -$6.58M 0.23% 118
2019
Q4
$17.8M Buy
273,771
+72,152
+36% +$4.7M 0.23% 114
2019
Q3
$12.8M Buy
201,619
+471
+0.2% +$30.8K 0.18% 157
2019
Q2
$13.6M Buy
201,148
+13,352
+7% +$878K 0.21% 129
2019
Q1
$12.2M Buy
187,796
+80,931
+76% +$5.38M 0.2% 144
2018
Q4
$6.68M Buy
106,865
+2,763
+3% +$193K 0.11% 248
2018
Q3
$8.04M Buy
104,102
+868
+0.8% +$65.6K 0.14% 216
2018
Q2
$7.31M Hold
103,234
0.14% 193
2018
Q1
$7.78M Buy
103,234
+18,171
+21% +$1.44M 0.16% 204
2017
Q4
$6.09M Buy
85,063
+541
+0.6% +$41.1K 0.14% 210
2017
Q3
$6.85M Sell
84,522
-2,803
-3% -$214K 0.15% 208
2017
Q2
$6.18M Sell
87,325
-316,589
-78% -$21.1M 0.14% 220
2017
Q1
$27.4M Buy
403,914
+101,336
+33% +$7.13M 0.22% 101
2016
Q4
$27.5M Sell
302,578
-75,485
-20% -$5.61M 0.26% 92
2016
Q3
$29.9M Sell
378,063
-19,673
-5% -$1.6M 0.32% 76
2016
Q2
$30.7M Buy
397,736
+75,923
+24% +$6.74M 0.34% 72
2016
Q1
$29.6M Sell
321,813
-1,407,324
-81% -$127M 0.32% 68
2015
Q4
$175M Sell
1,729,137
-306,204
-15% -$31.9M 1.94% 2
2015
Q3
$200M Buy
2,035,341
+148,733
+8% +$16.5M 2.2% 5
2015
Q2
$221M Sell
1,886,608
-265,812
-12% -$29M 2.16% 7
2015
Q1
$221M Buy
2,152,420
+52,996
+3% +$5.38M 1.92% 6
2014
Q4
$198M Buy
2,099,424
+418,913
+25% +$43.3M 1.88% 8
2014
Q3
$179M Buy
1,680,511
+13,631
+0.8% +$1.33M 1.74% 10
2014
Q2
$138M Buy
1,666,880
+126,218
+8% +$9.82M 1.33% 11
2014
Q1
$109M Buy
1,540,662
+303,007
+24% +$23.8M 1.16% 13
2013
Q4
$93M Buy
1,237,655
+1,139,985
+1,167% +$79.4M 1.06% 15
2013
Q3
$6.14M Sell
97,670
-98,637
-50% -$5.9M 0.08% 267
2013
Q2
$9.72M Buy
+196,307
New +$10.2M 0.15% 175

Other funds holding GILD

Westpac Banking Corp's GILD Position: Q1 2026 in Review

Westpac Banking Corp reduced its Gilead Sciences (GILD) stake by 13% in Q1 2026, selling an estimated $1.71M and leaving 80,033 shares worth $11.2M. The position accounts for 0.78% of the portfolio, ranked #20.

Westpac Banking Corp first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $221M in Q1 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Westpac Banking Corp held 80,033 shares of Gilead Sciences worth $11.2M as of Q1 2026.
  • Westpac Banking Corp sold 12,214 Gilead Sciences shares in Q1 2026, an estimated $1.71M.
  • Gilead Sciences made up 0.78% of Westpac Banking Corp's portfolio in Q1 2026, its #20 holding.
  • Westpac Banking Corp first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Westpac Banking Corp's Gilead Sciences position peaked at $221M in Q1 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.